VANGUARD GROUP INC 13D and 13G filings for Boston Scientific Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 5:00 pm Purchase | 2023-12-29 | 13G | Boston Scientific Corporation BSX | VANGUARD GROUP INC | 125,449,595 8.560% | 6,675,801 (+5.62%) | Filing |
| 2023-02-09 11:12 am Purchase | 2022-12-30 | 13G | Boston Scientific Corporation BSX | VANGUARD GROUP INC | 118,773,794 8.290% | 7,152,164 (+6.41%) | Filing |
| 2022-02-09 3:33 pm Purchase | 2021-12-31 | 13G | Boston Scientific Corporation BSX | VANGUARD GROUP INC | 111,621,630 7.830% | 840,472 (+0.76%) | Filing |
| 2021-02-10 10:39 am Purchase | 2020-12-31 | 13G | Boston Scientific Corporation BSX | VANGUARD GROUP INC | 110,781,158 7.740% | 1,764,309 (+1.62%) | Filing |
| 2020-02-12 09:27 am Purchase | 2019-12-31 | 13G | Boston Scientific Corporation BSX | VANGUARD GROUP INC | 109,016,849 7.820% | 5,175,601 (+4.98%) | Filing |